(Q33371289)

English

Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience (English)

1 reference

Europe PubMed Central

26 July 2017

immunosuppression

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jian Zhou

1

1 reference

Europe PubMed Central

26 July 2017

Jia Fan

2

1 reference

Europe PubMed Central

26 July 2017

Zheng Wang

3

1 reference

Europe PubMed Central

26 July 2017

Zhi-Quan Wu

4

1 reference

Europe PubMed Central

26 July 2017

Shuang-Jian Qiu

5

1 reference

Europe PubMed Central

26 July 2017

Xiao-Wu Huang

6

1 reference

Europe PubMed Central

26 July 2017

Yao Yu

7

1 reference

Europe PubMed Central

26 July 2017

Jian Sun

8

1 reference

Europe PubMed Central

26 July 2017

Yong-Sheng Xiao

9

1 reference

Europe PubMed Central

26 July 2017

Yi-Feng He

10

1 reference

Europe PubMed Central

26 July 2017

Yu-Qi Wang

11

1 reference

Europe PubMed Central

26 July 2017

Zhao-You Tang

12

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

26 July 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

26 July 2017

12

1 reference

Europe PubMed Central

26 July 2017

3114-3118

1 reference

Europe PubMed Central

26 July 2017

19

1 reference

Europe PubMed Central

26 July 2017

Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Mechanisms of resistance to rapamycins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

21 June 2018

The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124393

31 October 2018

A transformed view of cyclosporine

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I19.3114

21 January 2018

CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION

1 reference

https://pubmed.ncbi.nlm.nih.gov/16718799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus: a potent new immunosuppressant for liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16718799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/16718799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V12.I19.3114

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33371289&oldid=1950455792"